CHTR vs ERNA · P/E 11, rev $55.09B vs P/E 0.0, rev $582.0K
Charter Communications Inc (CHTR) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CHTR and ERNA stock pages for the full models.
Not investment advice.